skip to content


Issue No. 22 | October 6, 2017

News and Features

Statement from the Perinatal Guidelines Panel

On October 5, 2017, the Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission (the Panel) released the following statement:

A recent BMJ clinical practice guideline recommended that pregnant women living with HIV should not be treated with the combination of tenofovir/emtricitabine (TDF/FTC). After fully considering the results of the PROMISE study, both the Panel and the British HIV Association do not support these recommendations. The Panel found that there were important study design and statistical considerations that limit the generalizability of the PROMISE findings, and in consideration of all available evidence, the Panel concluded that the assessment of expected benefits and harms favored TDF/FTC over ZDV/3TC, leading the Panel to keep TDF/FTC as a Preferred recommendation and ZDV/3TC as an Alternative recommendation for antiretroviral-naive pregnant women living with HIV in the United States.

AIDSinfo Releases New Consumer Fact Sheet and Infographic

AIDSinfo has added a new fact sheet and a new infographic to our library of consumer education materials:

  • HIV and Sexually Transmitted Diseases (STDs) fact sheet:
    This fact sheet provides basic information about STDs, including risk factors, symptoms, and treatment. The fact sheet also explains the connection between HIV and other STDs.
  • Who's on Your Team? infographic:
    People with HIV depend on a team for support. View this infographic to see the many team members who help people with HIV stay healthy.
Visit the Understanding HIV/AIDS section of the AIDSinfo website to browse our complete collection of fact sheets and infographics and other consumer education materials. Visit infoSIDA to view the materials in Spanish.

October 15 is National Latinx AIDS Awareness Day

Though only 18% of the U.S. population, Hispanics/Latinos bear a disproportionate burden of HIV. According to the Centers for Disease Control and Prevention (CDC), in 2015, Hispanics/Latinos accounted for about 25% of all estimated new diagnoses of HIV infection in the United States and 6 dependent areas.

October 15 is set aside each year to promote HIV testing and prevention and access to HIV care in Hispanic/Latino communities nationwide. To learn more about this annual observance, browse our National Latinx AIDS Awareness Day webpage [en español].